Amlexanox
Amlexanox is an anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast cells, neutrophils, and mononuclear cells. Amlexanox also acts as a leukotriene D4 antagonist and a phosphodiesterase inhibitor. Amlexanox decreases the time ulcers take to heal as well as the pain associated with the ulcers.

Catalog Number | T1639 |
Alternative Name(s) | CHX3673 , Amoxanox , AA673 |
Research Area | Tyrosine Kinase/Adaptors|||Immunology/Inflammation|||Angiogenesis|||Others|||NF-Κb |
Molecular Formula | C16H14N2O4 |
CAS# | 68302-57-8 |
Purity | 100.00% |
SMILES | CC(C)c1cc2c(oc3nc(N)c(cc3c2=O)C(=O)O)cc1 |
Size | 25 mg |
Supplier Page | https://www.targetmol.com/compound/Amlexanox |
Additional Information | https://www.targetmol.com/datasheet/T1639 |